Warning! GuruFocus detected
1 Severe warning sign
with KMDA.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Kamada Ltd
NAICS : 325412
SIC : 2834
ISIN : IL0010941198
Compare
Compare
Traded in other countries / regions
KMDA.IsraelKMDA.USA IPO Date
2013-05-31Description
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.09 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 0.4 | |||||
| Interest Coverage | 30.38 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.92 | |||||
| Beneish M-Score | -2.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.4 | |||||
| 3-Year EBITDA Growth Rate | 75.3 | |||||
| 3-Year Book Growth Rate | 4.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 22.8 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 9.02 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.42 | |||||
| 9-Day RSI | 54.02 | |||||
| 14-Day RSI | 51.16 | |||||
| 3-1 Month Momentum % | 19.5 | |||||
| 6-1 Month Momentum % | 34.89 | |||||
| 12-1 Month Momentum % | 26.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.73 | |||||
| Quick Ratio | 2.14 | |||||
| Cash Ratio | 1.59 | |||||
| Days Inventory | 322.47 | |||||
| Days Sales Outstanding | 46.56 | |||||
| Days Payable | 82.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.7 | |||||
| Shareholder Yield % | 1.25 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.47 | |||||
| Operating Margin % | 12.46 | |||||
| Net Margin % | 8.99 | |||||
| FCF Margin % | 22.9 | |||||
| ROE % | 5.76 | |||||
| ROA % | 4.08 | |||||
| ROIC % | 8.2 | |||||
| 3-Year ROIIC % | -125.57 | |||||
| ROC (Joel Greenblatt) % | 13.75 | |||||
| ROCE % | 4.48 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27.31 | |||||
| Forward PE Ratio | 24.48 | |||||
| PE Ratio without NRI | 24.91 | |||||
| Shiller PE Ratio | 41.76 | |||||
| Price-to-Owner-Earnings | 12.9 | |||||
| PS Ratio | 2.44 | |||||
| PB Ratio | 1.55 | |||||
| Price-to-Tangible-Book | 3.2 | |||||
| Price-to-Free-Cash-Flow | 10.66 | |||||
| Price-to-Operating-Cash-Flow | 8.28 | |||||
| EV-to-EBIT | 22.82 | |||||
| EV-to-EBITDA | 11.49 | |||||
| EV-to-Revenue | 1.98 | |||||
| EV-to-Forward-Revenue | 1.93 | |||||
| EV-to-FCF | 8.54 | |||||
| Price-to-GF-Value | 1.35 | |||||
| Price-to-Projected-FCF | 1.24 | |||||
| Price-to-Median-PS-Value | 1.29 | |||||
| Price-to-Graham-Number | 1.86 | |||||
| Price-to-Net-Current-Asset-Value | 5.59 | |||||
| Earnings Yield (Greenblatt) % | 4.38 | |||||
| FCF Yield % | 9.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:KMDA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kamada Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 160.953 | ||
| EPS (TTM) ($) | 0.26 | ||
| Beta | 1 | ||
| 3-Year Sharpe Ratio | 0.27 | ||
| 3-Year Sortino Ratio | 0.42 | ||
| Volatility % | 25.88 | ||
| 14-Day RSI | 51.16 | ||
| 14-Day ATR ($) | 0.309822 | ||
| 20-Day SMA ($) | 6.9845 | ||
| 12-1 Month Momentum % | 26.18 | ||
| 52-Week Range ($) | 4.74 - 9.155 | ||
| Shares Outstanding (Mil) | 57.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kamada Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kamada Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kamada Ltd Frequently Asked Questions
What is Kamada Ltd(KMDA)'s stock price today?
The current price of KMDA is $7.10. The 52 week high of KMDA is $9.15 and 52 week low is $4.74.
When is next earnings date of Kamada Ltd(KMDA)?
The next earnings date of Kamada Ltd(KMDA) is 2025-05-01 Est..
Does Kamada Ltd(KMDA) pay dividends? If so, how much?
Kamada Ltd(KMDA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers